BHCM
MRTX

Brevan Howard Capital Management’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Brevan Howard Capital Management’s Portfolio MRTX Stock Details MRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-4,099
Closed -$241K – 1374
2023
Q4 		$241K Buy
+4,099
New +$241K ﹤0.01% 762